Oncology Central

Musings on value frameworks in cancer


Drug pricing is all over the news lately. Rarely does a day go by without seeing headlines like “The inexplicable and relentless rise of cancer drug prices” (Washington Post, 2 May 2016) or “Doctors Object to High Cancer-Drug prices” (Wall Street Journal, 23 July 2015). These are only a couple of examples of news outlets proclaiming that spending on cancer therapies is unsustainable. Implicit in the panic about cancer drug spending is the fundamental value question: “What is a cancer therapy worth?”

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.